I
Invibio
Advanced biomaterial polymers for surgical healthcare, enhancing patient outcomes with PEEK OPTIMA solutions
About Invibio
Invibio specializes in the development and supply of advanced biomaterial polymers, particularly PEEK OPTIMA, for use in medical devices. The company serves healthcare professionals and patients by providing materials that are used in a variety of applications, including spinal treatment, trauma fracture fixation, orthopedic procedures, and dental prosthetics. Invibio operates in the medical device market, partnering with manufacturers to integrate their polymers into products that meet regulatory standards. The business model focuses on leveraging market knowledge and regulatory expertise to assist partners in gaining product clearances, thereby generating revenue through material sales and partnerships. Invibio's materials are recognized for their clinical benefits, such as reduced bone loss in dental applications, and are cleared for use in the US and other regions. The company is ISO certified, ensuring high-quality standards in its operations.
Source: Dealroom company dataAt a glance
- Founded
- 2001
- Headquarters
- Thornton, United Kingdom
- Sector
- Health Tech & Medtech
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Invibio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Invibio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.